| http://www.w3.org/ns/prov#value | - In a judgment that focused mainly on the evidence and was that was not at first glance legally controversial, Arnold J concluded that the defendant's Deximune product would infringe Claims 1 and 48 of Novartis's patent for pharmaceutical compositions comprising cyclosporins".
|
